top of page
LATEST NEWS
LIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics
Access to extensive donor pool supports LIfT’s move into the clinic London, 03 April 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’),...
Apr 3
Our CEO Alex Blyth discusses what makes LIfT’s IMANs different
To kick LIfT’s science series off, we spoke to our CEO Alex Blyth regarding what makes IMANs different to regular neutrophils, what were...
Mar 20
LIfT BioSciences Secures Another Landmark US Patent, Strengthening Its Position as the World Leader in Neutrophil Immunotherapies
London, 13 March 2025 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil...
Mar 13
bottom of page